91 related articles for article (PubMed ID: 7561175)
1. Anticryptococcal activity of NK cell-enriched peripheral blood lymphocytes from human immunodeficiency virus-infected subjects: responses to interleukin-2, interferon-gamma, and interleukin-12.
Horn CA; Washburn RG
J Infect Dis; 1995 Oct; 172(4):1023-7. PubMed ID: 7561175
[TBL] [Abstract][Full Text] [Related]
2. Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15.
Seder RA; Grabstein KH; Berzofsky JA; McDyer JF
J Exp Med; 1995 Oct; 182(4):1067-77. PubMed ID: 7561680
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms by Which Interleukin-12 Corrects Defective NK Cell Anticryptococcal Activity in HIV-Infected Patients.
Kyei SK; Ogbomo H; Li S; Timm-McCann M; Xiang RF; Huston SM; Ganguly A; Colarusso P; Gill MJ; Mody CH
mBio; 2016 Aug; 7(4):. PubMed ID: 27555306
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.
Tripp CS; Wolf SF; Unanue ER
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3725-9. PubMed ID: 8097322
[TBL] [Abstract][Full Text] [Related]
5. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro.
Clerici M; Lucey DR; Berzofsky JA; Pinto LA; Wynn TA; Blatt SP; Dolan MJ; Hendrix CW; Wolf SF; Shearer GM
Science; 1993 Dec; 262(5140):1721-4. PubMed ID: 7903123
[TBL] [Abstract][Full Text] [Related]
6. [Study on ex vivo expansion of highly purified NK cells from human peripheral blood and changes in their function].
Li XH; Ma J; Wu XX; Wang FF; Li M; Da WM; Yu L; Gao CJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Jun; 30(6):404-8. PubMed ID: 19951535
[TBL] [Abstract][Full Text] [Related]
7. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.
Chehimi J; Starr SE; Frank I; Rengaraju M; Jackson SJ; Llanes C; Kobayashi M; Perussia B; Young D; Nickbarg E
J Exp Med; 1992 Mar; 175(3):789-96. PubMed ID: 1346797
[TBL] [Abstract][Full Text] [Related]
8. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro.
Carson WE; Ross ME; Baiocchi RA; Marien MJ; Boiani N; Grabstein K; Caligiuri MA
J Clin Invest; 1995 Dec; 96(6):2578-82. PubMed ID: 8675621
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cell stimulatory factor (NKSF)/IL-12 and cytolytic activities of PBL/NK cells from human immunodeficiency virus type-1 infected patients.
Sirianni MC; Ansotegui IJ; Aiuti F; Wigzell H
Scand J Immunol; 1994 Jul; 40(1):83-6. PubMed ID: 7913248
[TBL] [Abstract][Full Text] [Related]
10. Oligodeoxynucleotides containing palindrome sequences with internal 5'-CpG-3' act directly on human NK and activated T cells to induce IFN-gamma production in vitro.
Iho S; Yamamoto T; Takahashi T; Yamamoto S
J Immunol; 1999 Oct; 163(7):3642-52. PubMed ID: 10490958
[TBL] [Abstract][Full Text] [Related]
11. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells.
Chehimi J; Valiante NM; D'Andrea A; Rengaraju M; Rosado Z; Kobayashi M; Perussia B; Wolf SF; Starr SE; Trinchieri G
Eur J Immunol; 1993 Aug; 23(8):1826-30. PubMed ID: 8102101
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells.
Naume B; Gately M; Espevik T
J Immunol; 1992 Apr; 148(8):2429-36. PubMed ID: 1373169
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of natural killer cell activation and antibody-dependent cellular cytotoxicity by interferon-alpha and interleukin-12 in vaginal mucosae Sivmac251-infected Macaca fascicularis.
Poaty-Mavoungou V; Touré FS; Tevi-Benissan C; Mavoungou E
Viral Immunol; 2002; 15(1):197-212. PubMed ID: 11952142
[TBL] [Abstract][Full Text] [Related]
14. Augumentation of natural killer activity with exogenous interleukins in patients with HIV and pulmonary tuberculosis coinfection.
Ramana Rao PV; Rajasekaran S; Raja A
AIDS Res Hum Retroviruses; 2008 Nov; 24(11):1435-43. PubMed ID: 19000024
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cells from protein kinase C theta-/- mice stimulated with interleukin-12 are deficient in production of interferon-gamma.
Page KM; Chaudhary D; Goldman SJ; Kasaian MT
J Leukoc Biol; 2008 May; 83(5):1267-76. PubMed ID: 18263766
[TBL] [Abstract][Full Text] [Related]
16. Influence of interleukin-15 on CD8+ natural killer cells in human immunodeficiency virus type 1-infected chimpanzees.
Rodriguez AR; Arulanandam BP; Hodara VL; McClure HM; Cobb EK; Salas MT; White R; Murthy KK
J Gen Virol; 2007 Feb; 88(Pt 2):641-651. PubMed ID: 17251583
[TBL] [Abstract][Full Text] [Related]
17. Gene expression and secretion of cytokines and cytokine receptors from highly purified CD56+ natural killer cells stimulated with interleukin-2, interleukin-7 and interleukin-12.
Naume B; Johnsen AC; Espevik T; Sundan A
Eur J Immunol; 1993 Aug; 23(8):1831-8. PubMed ID: 7688307
[TBL] [Abstract][Full Text] [Related]
18. NK cells use perforin rather than granulysin for anticryptococcal activity.
Ma LL; Wang CL; Neely GG; Epelman S; Krensky AM; Mody CH
J Immunol; 2004 Sep; 173(5):3357-65. PubMed ID: 15322199
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulating effects in vitro of interleukin-2 and interferon-gamma on human blood and bone marrow mononuclear cells.
Kedar E; Rezai AR; Giorgi JV; Gale RP; Champlin RE; Mitsuyasu RT; Fahey JL
Nat Immun Cell Growth Regul; 1988; 7(1):13-30. PubMed ID: 2896298
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY
J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
